Cargando…
High-Throughput Architecture for Discovering Combination Cancer Therapeutics
PURPOSE: The amount of available next-generation sequencing data of tumors, in combination with relevant molecular and clinical data, has significantly increased in the last decade and transformed translational cancer research. Even with the progress made through data-sharing initiatives, there is a...
Autores principales: | Gianni, Matt, Qin, Yong, Wenes, Geert, Bandstra, Becca, Conley, Anthony P., Subbiah, Vivek, Leibowitz-Amit, Raya, Ekmekcioglu, Suhendan, Grimm, Elizabeth A., Roszik, Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873994/ https://www.ncbi.nlm.nih.gov/pubmed/30652536 http://dx.doi.org/10.1200/CCI.17.00054 |
Ejemplares similares
-
Targeting iNOS to increase efficacy of immunotherapies
por: Ekmekcioglu, Suhendan, et al.
Publicado: (2017) -
Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy
por: Kim, Sun-Hee, et al.
Publicado: (2018) -
Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018) -
A tool for discovering drug sensitivity and gene expression associations in cancer cells
por: Qin, Yong, et al.
Publicado: (2017) -
Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators
por: Qin, Yong, et al.
Publicado: (2017)